DSM India With almost EUR 9bn turnover and more than 22,000 people worldwide, Royal DSM has truly grown into an MNC. Within the global market, there is no doubt that India has become a country of rising opportunities… Can you first elaborate what DSM India represents to the Group worldwide? Every 5…
India Since the company’s foundation in 1993, Hetero has clearly come a long way. What were the key success factors at that time, which laid the groundwork of a successful company? First of all, I am a scientist by background, and before founding Hetero I had been working at Dr. Reddy’s…
Merck Limited Over the years, multinational corporations (MNCs) have increasingly been penetrating the Indian pharmaceutical markets. How have you observed this trend throughout your career? Based on India’s macro-economic growth of around 8 to 9 percent in the last 7 to 8 years, the pharmaceutical industry generally grows 4 to 5 percent…
Cockram Projects India is clearly a new location for Cockram, and what brought you here was your loyal customer Pfizer. After 3 years of project work, a permanent business has now also been established in India since 2010. Can you tell us how this first project worked out for you here? In…
Eli Lilly and Company (India) Pvt. Ltd. Having been director here in India between 1998-2002, and then again since 2006, you have clearly been in the front seat to observe the evolution of the Indian market. How have you experienced the increasing presence of MNCs in India? Absolutely … A transformation has clearly taken place over the…
India Dilip Surana of family-run Indian generics giant Micro Labs talks company performance, the evolution of the Indian pharma market, and strategy moving forward. Last year Micro Labs moved up in the rankings. How satisfied are you with the company’s performance in 2010? The company performed satisfactorily last year, showing good…
Merck Czech Republic Mr. Bartoš, you are celebrating your 15th anniversary with Merck this year, and your international career has offered you the opportunity to work throughout Europe. Over these years, how have you seen the 344-year-old Merck evolve and strengthen as a company, and how is this strength reflected here in the…
Merck Serono Turkey Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the two companies. Could you describe their integration process in Germany and which were the main synergies in the local market?…
AbMax You spent two decades in the US as an academic, executive, and entrepreneur, and then left to return to China and found AbMax. What’s the story behind how you came back to China ? I first went to the US in 1986 to pursue the American Dream. At that time,…
European Union Chamber of Commerce in China The Chamber recently released this year’s European Business in China Business Confidence Survey – what were some of its key takeaways? There are four main points to the Survey. The first has to do with not only China but the rest of the world. China’s growth has been stronger than…
Janssen Pharmaceutica Can you please start by giving to our readers an overview of your background and your involvement with Janssen? I am a Public Health graduate and have completed an MBA program, so I have a combination of science and business. I have been with the Pharma industry for over 20…
polski holding farmaceutyczny (PHF) Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission given by the State Treasury Minister was to privatise the three entities. You joined in March 2008, at a time when, if I may say, major steps…
See our Cookie Privacy Policy Here
